Meta Pixel

News and Announcements

Clinical Trial in Dogs is now open for accrual

  • Published October 02, 2014 11:28AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

ASX Release; Thursday 02 October 2014

PhamAus Limited (“PharmAust”or “ the Company”) (ASX:PAA& PAAO) is pleased to announce that following reformulation of PPL-1 into “soft-gel” capsules to improve palatability for dogs, the Animal Referral Hospital (ARH) in Homebush NSW, with principal investor Dr Angela Frimberger, announced today initiation of accrual of canine patients. This announcement is intended to alert dog owners with pest diagnosed with cancer that the trial is open for recruitment.

The trial evaluates the drug PPL-1, which has shown promising anti-cancer results in vitro and in mice. Previous safety studies in dogs have shown the drug is extremely well tolerated. The trial has been approved by the Director General’s Animal Care and Ethics Committee for the treatment of dogs with soft tissue sarcomas, melanomas, and lymphomas, using PPL-1 in a “soft-gel” capsule.

To view the full ASX Release, please click here.

 

 

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Join over 45,000+ sophisticated investors

Join Now